Study of erythrocyte sedimentation rate in patients with pulmonary tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 309s Year: 2001
The relation between blood leucocyte count, erythrocyte sedimentation rate, high sensitive C-reactive protein and pulmonary parenchymal infiltration in young male patients with Chlamydia pneumoniae pneumonia Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009
Decreasing level of serum ADA: A valuable predictor of treatment in smear positive tuberculosis Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis Year: 2011
Unexpected reduction of erythrocyte sedimentation rate (ESR) following acute administration of high dose of N-acetycysteine Source: Eur Respir J 2005; 26: Suppl. 49, 574s Year: 2005
T-cell biomarkers for diagnosis of tuberculosis: candidate evaluation by a simple whole blood assay for clinical translation Source: Eur Respir J, 51 (3) 1800153; 10.1183/13993003.00153-2018 Year: 2018
White blood cell count, C-reactive protein and erythrocyte sedimentation rate in varicella pneumonia in adults Source: Eur Respir J 2004; 24: Suppl. 48, 51s Year: 2004
Neopterin levels differential diagnosis of active and inactive pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 341s Year: 2006
Is PPD still a screening diagnostic tool for tuberculosis alone, or for something else also? Source: Eur Respir J 2006; 28: Suppl. 50, 21s Year: 2006
Clinical significance of low serum isoniazid level among the patients with drug-sensitive pulmonary tuberculosis who showed delayed smear or culture conversion. Source: International Congress 2018 – New developments in tuberculosis Year: 2018
A change in blood transcriptional signatures accompanies successful tuberculosis therapy Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools Year: 2012
Detection of metabolic profile in urine for diagnosing pediatric tuberculosis Source: International Congress 2019 – Tuberculosis: diagnosis and scores Year: 2019
Performance of a commercial IFN-γ blood assay for monitoring treatment efficacy in active pulmonary tuberculosis Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis Year: 2009
Serum lipids as biomarkers for therapeutic monitoring of latent tuberculosis infection Source: Eur Respir J 2013; 42: 547-550 Year: 2013
Haematological – radiological findings at the beginning of treatment and the time period needed to obtain a negative sputum smear in active lung tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 417s Year: 2004
The use of interferon-γ-based blood tests for the detection of latent tuberculosis infection Source: Eur Respir J 2006; 28: 1-3 Year: 2006
Altered pulmonary blood volume distribution as a biomarker for predicting outcomes in COVID-19 disease Source: Eur Respir J, 58 (3) 2004133; 10.1183/13993003.04133-2020 Year: 2021
Are interferon- gamma release assays useful for diagnosing active tuberculosis in a high-burden setting? Source: Eur Respir J 2011; 38: 649-656 Year: 2011
The relation of hemoglobin, hematocrit, leucocyte and platelet levels to the severity of lesion in patients with pulmonary tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 310s Year: 2001
The relationship between level of C-reactive protein in blood serum and clinical manifestations of the disease in patients with pulmonary tuberculosis Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010
PCR based method for accurate diagnosis of mycobacterial disease and description of clinical profile of disease caused by non tuberculous mycobacteria Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012